Dosimetric impact of contouring and needle reconstruction uncertainties in US-, CT- and MRI-based high-dose-rate prostate brachytherapy treatment planning.

BACKGROUND AND PURPOSE The purpose was to evaluate the dosimetric impact of target contouring and needle reconstruction uncertainties in an US-, CT- and MRI-based HDR prostate BT treatment planning. MATERIAL AND METHODS US, CT, and MR images were acquired post-needle insertion in 22 HDR-BT procedures for 11 consecutive patients. Dose plans were simulated for an US-, CT- and MRI-based HDR-BT treatment planning procedure. Planning uncertainties in US- and CT-based plans were evaluated using MRI-based planning as reference. Target (CTVProstate) was re-contoured on MRI. Dose results were expressed in total equivalent dose given in 2Gy fractionation dose for EBRT (46Gy) plus 2 HDR-BT fractions. RESULTS Uncertainties in US- and CT-based planning caused the planned CTVProstate-D90% to decrease with a mean of 2.9±5.0Gy (p=0.03) and 2.9±2.9Gy (p=0.001), respectively. The intra-observer contouring variation on MRI resulted in a mean variation of 1.6±1.5Gy in CTVProstate-D90%. Reconstruction uncertainties on US resulted in a dose variation of±3Gy to the urethra, whereas data for CT were not available for this. CONCLUSIONS Uncertainties related to contouring and reconstruction in US- and CT-based HDR-BT treatment plans resulted in a systematic overestimation of the prescribed target dose. Inter-modality uncertainties (US and CT versus MR) were larger than MR intra-observer uncertainties.

[1]  J J Prete,et al.  Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. , 1998, Radiology.

[2]  C. Koning,et al.  Improved tumour control probability with MRI-based prostate brachytherapy treatment planning , 2013, Acta oncologica.

[3]  Giuseppe Palermo,et al.  Imaging in Prostate Cancer Staging: Present Role and Future Perspectives , 2012, Urologia Internationalis.

[4]  Daniel Berger,et al.  Dosimetric impact of interobserver variability in MRI-based delineation for cervical cancer brachytherapy. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  Baris Turkbey,et al.  Imaging localized prostate cancer: current approaches and new developments. , 2009, AJR. American journal of roentgenology.

[6]  J. Pouliot,et al.  American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. , 2012, Brachytherapy.

[7]  Wendy L. Smith,et al.  Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR. , 2007, International journal of radiation oncology, biology, physics.

[8]  P. Hoskin,et al.  Dosimetric predictors of biochemical control of prostate cancer in patients randomised to external beam radiotherapy with a boost of high dose rate brachytherapy. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  Gabor Fichtinger,et al.  Characterization of ultrasound elevation beamwidth artifacts for prostate brachytherapy needle insertion. , 2011, Medical physics.

[10]  R. Pötter,et al.  GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  Michael C. Joiner,et al.  Basic Clinical Radiobiology , 2009 .

[12]  Nawaid Usmani,et al.  Comparison of prostate volume, shape, and contouring variability determined from preimplant magnetic resonance and transrectal ultrasound images. , 2012, Brachytherapy.

[13]  W. De Neve,et al.  Magnetic resonance imaging anatomy of the prostate and periprostatic area: a guide for radiotherapists. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  J. Dimopoulos,et al.  Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  A novel method for accurate needle-tip identification in trans-rectal ultrasound-based high-dose-rate prostate brachytherapy. , 2011, Brachytherapy.

[16]  J. Sylvester,et al.  Prostate brachytherapy seed identification on post-implant TRUS images. , 2003, Medical physics.

[17]  C. Kirisits,et al.  Review of clinical brachytherapy uncertainties: Analysis guidelines of GEC-ESTRO and the AAPM☆ , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  Christian Kirisits,et al.  Uncertainties in image guided adaptive cervix cancer brachytherapy: impact on planning and prescription. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  J J Prete,et al.  Comparison of MRI- and CT-based post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy. , 1998, Radiation oncology investigations.

[20]  David Beyer,et al.  Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy. , 2002, International journal of radiation oncology, biology, physics.

[21]  P. Hoskin,et al.  Brachytherapy: current status and future strategies -- can high dose rate replace low dose rate and external beam radiotherapy? , 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

[22]  F. Waterman,et al.  The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry. , 2006, Brachytherapy.

[23]  G. De Meerleer,et al.  Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning. , 2007, European journal of radiology.

[24]  The influence of a rectal ultrasound probe on the separation between prostate and rectum in high-dose-rate brachytherapy. , 2015, Brachytherapy.

[25]  Josef Nilsson,et al.  Prostate volume determination: differential volume measurements comparing CT and TRUS. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  New interstitial HDR brachytherapy technique for prostate cancer: CT based 3D planning after transrectal implantation. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  M van Herk,et al.  Definition of the prostate in CT and MRI: a multi-observer study. , 1999, International journal of radiation oncology, biology, physics.

[28]  Karin Haustermans,et al.  Prostate post-implant dosimetry: interobserver variability in seed localisation, contouring and fusion. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  J. Montie,et al.  Functional anatomy of the prostate: implications for treatment planning. , 2005, International journal of radiation oncology, biology, physics.